Under the agreement iECURE plans to advance Precision's PBGENE-PCSK9 candidate into Phase 1 studies and gain access to Precision's PCSK9-directed ARCUS nuclease to develop additional gene-editing ...

FARMINGDALE, N.Y. - December 5, 2018 - Precision Label Corporation, a New York-based converter serving major cosmetic brands, is expanding its digital production capabilities with the addition of ...